OCT in Borderline Coronary Artery Lesions
The Safety and Efficacy of OCT in the Evaluation and Treatment of Angiographically Borderline Coronary Artery Lesions
Sponsor: The First Affiliated Hospital with Nanjing Medical University
A NA clinical study on Borderline Coronary Artery Lesions and Coronary Angiography (CAG), this trial is completed. The trial is conducted by The First Affiliated Hospital with Nanjing Medical University and has accumulated 9 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2019 — Aug 2020 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2017 — Mar 2018 [monthly]
Not Yet Recruiting NA
-
Aug 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The First Affiliated Hospital with Nanjing Medical University
For direct contact, visit the study record on ClinicalTrials.gov .